These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 25845125)
1. Current Indian scenario on the use of oral anticoagulants. J Assoc Physicians India; 2014 Jun; 62(6 Suppl):28-9. PubMed ID: 25845125 [No Abstract] [Full Text] [Related]
6. Role of the new oral anticoagulants in treatment of venous throboembolism. Minichiello T; Garcia D J Thromb Thrombolysis; 2013 Aug; 36(2):149-54. PubMed ID: 23532365 [No Abstract] [Full Text] [Related]
8. Determinants and consequences of differences in quality of anticoagulation therapy with vitamin K antagonists. Tichelaar V; Meijer K Thromb Res; 2015 Aug; 136(2):183-4. PubMed ID: 26024823 [No Abstract] [Full Text] [Related]
9. [Anticoagulation in atrial fibrillation. Stroke can be prevented this way]. Thorsten L MMW Fortschr Med; 2009 Sep; 151(36):53. PubMed ID: 19813543 [No Abstract] [Full Text] [Related]
10. [Oral anticoagulants. Large study finds minor risk of hemorrhage in the elderly]. MMW Fortschr Med; 2011 Sep; 153(37):16. PubMed ID: 21950182 [No Abstract] [Full Text] [Related]
11. Vitamin K antagonist use for all patients with hypertrophic cardiomyopathy and atrial fibrillation: analysis of the literature and guideline review. Oliphant CS; McCullough J; Hashim T; Khouzam RN Future Cardiol; 2014 Mar; 10(2):229-33. PubMed ID: 24762250 [TBL] [Abstract][Full Text] [Related]
12. Prevention of stroke in patients with atrial fibrillation. Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692 [No Abstract] [Full Text] [Related]
13. [Hematochezia during anticoagulation. Pulmonary embolism as a life saver?]. Stiefelhagen P MMW Fortschr Med; 2013 Dec; 155(21-22):30. PubMed ID: 24724260 [No Abstract] [Full Text] [Related]
14. New oral anticoagulants: an emergency department overview. Wood P Emerg Med Australas; 2013 Dec; 25(6):503-14. PubMed ID: 24224462 [TBL] [Abstract][Full Text] [Related]
15. New oral anticoagulants versus vitamin K antagonists in countries with good INR control. Coppens M Neth J Med; 2013 May; 71(4):168-9. PubMed ID: 23723109 [No Abstract] [Full Text] [Related]
16. GARFIELD: a window on the real-life treatment of atrial fibrillation - South Africa joins the GARFIELD registry. Aalbers J Cardiovasc J Afr; 2012 Oct; 23(9):528. PubMed ID: 23108524 [No Abstract] [Full Text] [Related]
17. Edoxaban (Savaysa) for the Prevention of Thromboembolic Events. Oung AB Am Fam Physician; 2018 Apr; 97(8):529-530. PubMed ID: 29671492 [No Abstract] [Full Text] [Related]
18. [Stroke prevention in atrial fibrillation. Marcumar alternative in sight]. Einecke D MMW Fortschr Med; 2009 Sep; 151(38):12-4. PubMed ID: 19831172 [No Abstract] [Full Text] [Related]
19. Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation. Liew A; Eikelboom JW; O'Donnell M Curr Opin Cardiol; 2012 Jul; 27(4):331-9. PubMed ID: 22573171 [TBL] [Abstract][Full Text] [Related]
20. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy. Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]